Breast Cancer: 1,219 Real Stories

1,219 stories match breast cancer. 974 of them mention surgery.

Cancer Stories

Rosanna, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Rosanna's Survivor Story

Patient Info: Rosanna Silber, Female, Under 40 | Stage I

Rosanna had no evidence of cancer after treatment for Stage I breast cancer and later cervical cancer, with ongoing checkups every 6 months for cervical cancer and annually for breast cancer.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Amy, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Amy's Survivor Story

Patient Info: Amy Mannarino, Female, 50s | Stage IV

Metastatic Site: Brain

After brain metastasis surgery and 3 radiation sessions, Amy was doing well with no evidence of disease; the source specifically distinguishes NED from being cured or cancer-free in the setting of metastatic disease.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Nicole, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Jim, who was diagnosed with Breast CancerBreast Cancer

HER2-Positive Breast Cancer: Jim's Patient Story

Patient Info: Jim Keegan, Male, 70+

Biomarkers: HER2-positive; BRCA1/BRCA2 negative

Jim completed surgery, chemotherapy and 1 year of Herceptin for early-stage HER2-positive male breast cancer, then continued tamoxifen and yearly MSK surveillance while advocating for male breast cancer awareness.

Memorial Sloan Kettering
OutcomeCare Ongoing
Michelle, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of Hope
OutcomeCancer-Free / NED
Dwan, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Dwan's Survivor Story

Patient Info: Dwan Thomas, Female | Stage II

Biomarkers: HER2-negative; estrogen-positive

Dwan completed treatment for Stage II HER2-negative, estrogen-positive invasive ductal carcinoma in 2017 and later became active in MD Anderson advocacy and fundraising efforts.

MD Anderson
OutcomeSurvivorship / Completed Treatment
Cookie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Cookie's Survivor Story

Patient Info: Cookie Joe, female | Stage III

Biomarkers: triple-negative

More than 5 years after her April 2021 diagnosis, she remains cancer-free (since December 2022) and continues breast-cancer advocacy, fundraising, and blood-donation efforts.

MD Anderson
OutcomeCancer-Free / NED
Jennifer, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Jennifer's Patient Story

Patient Info: Jennifer Feinberg, Female, 40s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: brain

8+ years after her initial breast cancer diagnosis, she was living with metastatic HER2-positive breast cancer with brain metastases and receiving trastuzumab as her tenth line of treatment.

Dana-Farber
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

HER2-positive breast cancer complicated by severe anemia during chemotherapy

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-positive; germline BRCA1 likely pathogenic mutation

At 4.5-year follow-up, she remained free of breast-cancer recurrence and had no recurrence of the severe treatment-related anemia.

PubMed Central
OutcomeCancer-Free / NED
Jane, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Jane's Patient Story

Patient Info: Jane, Female, 50s | Stage II

Nearly 3 years into her breast-cancer journey, she was continuing long-term hormone therapy and active patient advocacy.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
A patient, who was diagnosed with Breast Squamous Cell CarcinomaBreast Cancer

Complete response after chemotherapy for metaplastic breast cancer

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-negative; weak PR-positive; HER2-negative

Surgery found no residual invasive or in situ breast cancer, and all 3 sentinel lymph nodes were negative, confirming a pathologic complete response.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Radiation-related morphea years after breast cancer treatment

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative

At follow-up in March 2026, more than 10 years after her breast cancer diagnosis, she remained free of oncologic recurrence and had completed 10 years of tamoxifen.

PubMed Central
OutcomeCancer-Free / NED
Tiffany, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Tiffany's Patient Story

Patient Info: Tiffany Andrews, Female, Under 40 | Stage IV

Biomarkers: HER2-positive; ER-negative at recurrence

Metastatic Site: lungs|brain

Tiffany is living with metastatic HER2-positive breast cancer and continues treatment through a clinical trial after progression in the lungs and brain.

MD Anderson
OutcomeCare Ongoing
Naomi, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Naomi's Patient Story

Patient Info: Naomi Arbel-Brodd, Female | Stage II

Twenty years after her 2006 diagnosis, she had returned to UT MD Anderson as a weekly volunteer supporting other women receiving breast cancer care.

MD Anderson
OutcomeNot reported
A patient, who was diagnosed with Stage II Breast CancerBreast Cancer

HER2-Positive Breast Cancer Treatment Followed by Multiple Myeloma

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER-negative; PR-negative; HER2 3+; Ki-67 70%

Postoperative imaging showed no breast cancer recurrence or distant metastasis, and the breast cancer was described as stable when a separate multiple myeloma diagnosis was made.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Breast cancer treatment changed after severe colitis

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: HER2-positive, ER-negative, PR-negative

In April 2025, follow-up evaluation showed no evidence of breast cancer recurrence.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Breast cancer spread into a separate kidney cancer

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2 equivocal

Metastatic Site: bone|kidney

The kidney surgery unexpectedly confirmed a new breast-cancer metastasis, changing her breast cancer status to systemic progression. A new systemic treatment was planned.

PubMed Central
OutcomeSetback / Progression
Famke, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Famke's Survivor Story

Patient Info: Famke, Female, Under 40 | Stage III

Famke received surgery, chemotherapy and radiation and celebrated 5 years since diagnosis while continuing long-term hormone therapy.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing / Survivorship
Tamara, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Tamara's Patient Story

Patient Info: Tamara Mitchell, Female | Stage I

Tamara continued annual breast cancer screening while her leukemia and kidney cancer were being managed separately.

MD Anderson
OutcomeNot reported
A patient, who was diagnosed with Stage IV Small Cell Lung CancerBreast Cancer

Rare Breast Neuroendocrine Cancer That Recurred in the Liver

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: Chromogranin-positive; synaptophysin-positive; GATA-3-positive; ER-positive; PR negative on repeat biopsy and 40% positive on the mastectomy specimen; HER2-negative; Ki-67 85–95%

Metastatic Site: Liver; abdominal lymph nodes

After temporary responses to surgery and repeated chemotherapy, the cancer returned repeatedly in the liver and had spread to abdominal lymph nodes by May 2025. A new chemotherapy regimen was planned.

PubMed Central
OutcomeSetback / Progression